Print Page

Letters to Healthcare Providers
 
Type 2 diabetes medicines containing saxagliptin and alogliptin: risk of heart failure (Letter to Healthcare Professionals)
 
 
 
Attachment:
  1. Type 2 diabetes medicines containing saxagliptin and alogliptin: risk of heart failure  
Related Information:
The United States: FDA Drug Safety Communication: FDA adds warnings about heart ... Posted 2016-04-06
The United States: Saxagliptin (marketed as Onglyza and Kombiglyze XR): Drug Saf... Posted 2014-02-12
Saxagliptin- FDA to Review Heart Failure Risk (Letter to Healthcare Professional... Posted 2014-02-12
 
back